Abstract

Gingival enlargement, [sometimes abbreviated to GO (gingival overgrowth)] is an increase in the size of the gingiva. It is a common feature of gingival disease. Gingival enlargement is a well known side-effect of drugs like anticonvulsants, calcium channel blockers and immunosuppressant. A case of amlodipine induced gingival enlargement was reported and after drug substitution when the patient was treated non-surgically (scaling and root planing), the enlargement subsides to a normal state which suggested the effectiveness of non-surgical periodontal therapy in the treatment of drug induced gingival enlargement.
 Keywords: Anticonvulsants, Immunosuppressants, Calcium channel blockers, gingival enlargement

Highlights

  • Drug induced gingival enlargement was first reported in 1939 associated with chronic use of antiepileptic drug phenytoin.[1]

  • A case of amlodipine induced gingival enlargement was reported and after drug substitution when the patient was treated non-surgically, the enlargement subsides to a normal state which suggested the effectiveness of non-surgical periodontal therapy in the treatment of drug induced gingival enlargement

  • Gingival enlargement may be associated with the administration of three different classes of drugs, all producing a similar response: anticonvulsants

Read more

Summary

Case Report

|| ISSN(online): 2589-8698 || ISSN(print): 2589-868X || International Journal of Medical and Biomedical Studies. Available Online at www.ijmbs.info PubMed (National Library of Medicine ID: 101738825). Index Copernicus Value 2018: 75.71 Volume 3, Issue 11; November: 2019; Page No 112-114. EFFECTIVENESS OF NON-SURGICAL PERIODONTAL THERAPY ON AMLODIPINE INDUCED GINGIVAL ENLARGEMENT: A CASE REPORT Dagar Mona, Kataria Prerna2 1MDS, Sr. Lecturer, Department of Periodontology, DJ College of Dental Sciences & Research, Modinagar, (U.P.) 2MDS, Professor, Department of Periodontology, DJ College of Dental Sciences & Research, Modinagar, (U.P.). Article Info: Received 03 October 2019; Accepted 14 November.

Introduction
Findings
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.